According to our latest study on “Ablation Device Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis” the market was valued at US$ 8,325.32 million in 2022 and is projected to reach US$ 16,020.33 million by 2030; it is estimated to register a CAGR of 8.5 % from 2022 to 2030. The report highlights the key factors driving the ablation device market growth and prominent players with their developments in the market.
Ablation refers to the surgical removal of an organ, structure, or part. Ablation devices use heat (usually generated by radio frequency, RF, energy, or a laser) or extreme cold to cause minor burns.
Get Sample Copy @ https://www.theinsightpartners.com/sample/TIPRE00003095/
The ablation device market, by device, is segmented into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. The radiofrequency devices segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022-2030. Radiofrequency ablation is a minimally invasive procedure used in the treatment of myomas, bones, tissues, thyroid, endometrium, varicose veins, and others. It is an alternative to the traditional surgical operation. The ablation device market, by application, is segmented into cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. The cardiovascular disease treatment segment held a larger market share in 2022; also, the same segment is anticipated to register a higher CAGR during 2022-2030.
The ablation device market, by end users, is segmented into hospitals and clinics, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held the largest market share, and the same segment is anticipated to register the highest CAGR during 2022–2030. Hospitals and clinics are the primary end users of ablation devices as they offer a wide range of medical services, including non-invasive procedures that require ablation.
Abbott Laboratories, AngioDynamics, Inc., AtriCure, Inc., Biotronik, Boston Scientific Corporation, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, and Smith & Nephew PLC are among the leading companies operating in the global ablation device market.
Companies operating in the ablation device market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the ablation device market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall ablation device market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
About Us:
The Insight Partners is a market research solution and consultation company. Specializing in syndicate market research, our team helps clients in their hunt for revenue pockets in several industries. A team of 250+ research experts is dedicated to offering the most relevant, data-driven, and trustworthy market insights and consultation.
Contact Us:
If you have any queries about this report or if you would like further information, please contact u
The Insight Partners
Phone: +1-646-491-9876
E-mail: [email protected]
About Author
